Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTransense Regulatory News (TRT)

Share Price Information for Transense (TRT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 108.50
Bid: 107.00
Ask: 110.00
Change: 6.00 (5.85%)
Spread: 3.00 (2.804%)
Open: 102.50
High: 108.50
Low: 102.50
Prev. Close: 102.50
TRT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Share Repurchase Programme

22 Feb 2022 07:01

RNS Number : 3474C
Transense Technologies PLC
22 February 2022
 

 

This announcement contains inside information for the purposes of the UK version of the Market Abuse Regulation 596/2014/EU (which is part of UK law by virtue of the European Union (Withdrawal) Act 2018)

 

 

Transense Technologies plc

("Transense" or "the Company")

 

Share Repurchase Programme

 

Transense Technologies plc (AIM: TRT), the developer of specialist sensor systems, is pleased to announce that it will commence a programme to conduct market purchases of ordinary shares of 10 pence each in the Company ("Ordinary Shares") up to a maximum aggregate purchase price of £300,000 (the "Programme").

 

The Company has entered into an arrangement with Shard Capital Stockbrokers ("Shard") in relation to the Programme where Shard will make the trading decisions concerning the timing of the market purchases of Ordinary Shares independently of and uninfluenced by the Company, with such trading decisions being in accordance with the terms of the Programme. Purchases may continue during any periods during the term of the Programme when the Company itself would be prohibited from dealing by the UK version of the Market Abuse Regulation 596/2014/EU (which is part of UK law by virtue of the European Union (Withdrawal) Act 2018) ("UK MAR"). The Company reserves the right to terminate the programme if at any time it deems this to be appropriate and would make an announcement in advance of so doing.

 

The Company confirms that it currently has no unpublished inside information.

 

The Programme will commence today, 22 February 2022, and will continue until 31 October 2022 unless terminated earlier.

 

The Programme will be conducted by the Company in accordance with and under the terms of the general authority granted by the Company's shareholders at the Company's Annual General Meeting on 23 November 2021 to purchase up to 1,643,774 Ordinary Shares. This authority will expire at the earlier of the end of the next Annual General Meeting of the Company or 23 February 2024.

 

Any market purchases will be conducted in compliance with the following restrictions regarding price conditions:  

· the minimum price (exclusive of any expenses) at which any Ordinary Share may be purchased shall be its nominal value of 10 pence

· the maximum price (exclusive of any expenses) at which any Ordinary Share may be purchased shall be the higher of: (i) an amount equal to 5 per cent, above the average of the middle market quotations of an Ordinary Share as derived from the London Stock Exchange Daily Official List for the five business days immediately preceding the date of such purchase, and (ii) the higher of the price of the last independent trade and the highest current independent bid on the trading venue where the purchase is carried out.

 

Due to the limited liquidity in the Ordinary Shares, any market purchase of Ordinary Shares pursuant to the Programme on any trading day could represent a significant proportion of the daily trading volume in the Ordinary Shares on AIM and could exceed 25 per cent. of the average daily trading volume. This means that the Company will not benefit from the exemption contained in Article 5(1) of UK MAR.

 

The objective of the Programme is to offset the dilutive impact of share awards to directors and employees.

 

Ordinary Shares acquired as a result of the Programme will be held by the Company in treasury and in accordance with the Companies Act 2006, will not have any voting rights. It is anticipated that any Ordinary Shares held in treasury but surplus to unexercised option requirements from time to time will be cancelled.

For further information please visit www.transense.com or contact:

Transense Technologies plc

Nigel Rogers (Executive Chairman)

Melvyn Segal (CFO)

Via Walbrook PR

Allenby Capital (Nominated Adviser and Broker)

Jeremy Porter / George Payne (Corporate Finance)

Tony Quirke (Sales and Corporate Broking)

Tel: +44 (0)20 3328 5656

Walbrook PR

Tom Cooper/Nick Rome/Nicholas Johnson

Tel: +44 (0)20 7933 8780

Transense@walbrookpr.com

 

 

Notes to Editors:

 

Transense develops and supplies wireless sensor technology and systems. The Company has three business areas:

· SAW, patent protected Surface Acoustic Wave sensor technology that provides real time measurement of torque, temperature, pressure and strain, that is used to improve efficiency, performance and safety of propulsion systems and machinery;

· Translogik, smart, connected commercial vehicle tyre inspection equipment, used by vehicle fleets to more easily gather and maintain accurate tyre safety and condition data; and

· iTrack, a tyre pressure monitoring system for off-highway machinery, licensed exclusively to Bridgestone Corporation, the world's largest tyre producer, under a ten-year deal.

Target market sectors include automotive, aerospace and industrial machinery. The Group's strategy is to leverage excellence in innovation, know-how in wireless sensor technologies and form industry partnerships in these global growth sectors to maximise shareholder value through sustained revenue growth from all three principal technologies - SAW, iTrack and Translogik.

Transense is headquartered in Oxfordshire, UK, and was admitted to trading on AIM, a market operated by the London Stock Exchange (AIM: TRT), in 1999.

For further information please contact transense@walbrookpr.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSKFLFLLLLEBBK
Date   Source Headline
29th Jun 20124:20 pmRNSInterim Results
29th Jun 20127:00 amRNSTotal Voting Rights
25th Jun 20127:00 amRNSMichelin uses iProbe in new 'communicating' tyres
22nd Jun 201211:05 amRNSTranslogik further order from EDP
15th Jun 201210:47 amRNSStrategic Distribution Agreement in Saudi Arabia
12th Jun 20127:00 amRNSStrategic Distribution Agreement in Malaysia
11th Jun 20127:00 amRNSAppointment of Group Executive Finance Director
6th Jun 20124:41 pmRNSExercise of Warrants
31st May 201210:53 amRNSTotal Voting Rights
31st May 20127:00 amRNSiTrack success in southern Africa
29th May 20127:00 amRNSChinese partner places order worth over USD 500k
17th May 20127:00 amRNSFirst IntelliSAW customer in India
1st May 20122:23 pmRNSExercise of Warrants
11th Apr 20127:00 amRNSIntelliSAW confirmed orders of USD 550k
4th Apr 20127:00 amRNSBridgestone Brazil Update
23rd Mar 20127:00 amRNSExclusive Distribution Agreement for India
5th Mar 20124:30 pmRNSHolding(s) in Company
28th Feb 20127:00 amRNSIntelliSAW US Representative Agreement
23rd Feb 20127:00 amRNSTranslogik order from EDP for Michelin Euromaster
6th Feb 20127:00 amRNSBridgestone Brazil order for iProbe
3rd Feb 201212:46 pmRNSReplacement - Change of Adviser
1st Feb 20127:00 amRNSChange of Adviser
17th Jan 20127:00 amRNSIntelliSAW Volume Production Shipments
30th Dec 20117:00 amRNSTotal Voting Rights
28th Dec 201112:25 pmRNSHolding(s) in Company
23rd Dec 20119:01 amRNSChange of status to executive director and award
21st Dec 20112:00 pmRNSResult of Fundraising
13th Dec 20119:34 amRNSExtension of offer period
12th Dec 20117:00 amRNSExclusive Distribution Agreement in Brazil
8th Dec 20117:00 amRNSStrategic Partnership in China
7th Dec 20117:00 amRNSStrategic Partnership
23rd Nov 20117:00 amRNSOtraco iTrack Trial
21st Nov 201110:00 amRNSProposed Fundraising - Replacement
21st Nov 20117:00 amRNSProposed Fundraising
20th Oct 20117:00 amRNSContract - Pirelli Brazil
30th Sep 20117:00 amRNSHalf Yearly Report
28th Sep 20117:00 amRNSNew Trading Division
27th Sep 20117:00 amRNSShare Allotment
26th Sep 20117:00 amRNSUpdate
16th Sep 20118:38 amRNSDirector/PDMR Shareholding
16th Aug 201111:32 amRNSJoint Development Agreement - McLaren Electronics
23rd Jun 20092:48 pmRNSDirector/PDMR Shareholding
8th Jun 20097:00 amRNSRe Translogik Limited
29th Apr 20091:08 pmRNSJt Development with McLaren Electronic Systems Ltd
7th Apr 20097:00 amRNSFinal Results
6th Mar 200911:18 amRNSNotice of Preliminary Results
4th Feb 20095:00 pmRNSDirector/PDMR Shareholding
2nd Feb 20092:50 pmRNSGrant of Options
30th Jan 20092:37 pmRNSDirectorate Change
30th Jan 20091:47 pmRNSContract Win

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.